<code id='0894EC4B3D'></code><style id='0894EC4B3D'></style>
    • <acronym id='0894EC4B3D'></acronym>
      <center id='0894EC4B3D'><center id='0894EC4B3D'><tfoot id='0894EC4B3D'></tfoot></center><abbr id='0894EC4B3D'><dir id='0894EC4B3D'><tfoot id='0894EC4B3D'></tfoot><noframes id='0894EC4B3D'>

    • <optgroup id='0894EC4B3D'><strike id='0894EC4B3D'><sup id='0894EC4B3D'></sup></strike><code id='0894EC4B3D'></code></optgroup>
        1. <b id='0894EC4B3D'><label id='0894EC4B3D'><select id='0894EC4B3D'><dt id='0894EC4B3D'><span id='0894EC4B3D'></span></dt></select></label></b><u id='0894EC4B3D'></u>
          <i id='0894EC4B3D'><strike id='0894EC4B3D'><tt id='0894EC4B3D'><pre id='0894EC4B3D'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:32
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          FDA panel gives mixed vote on blood pressure devices
          FDA panel gives mixed vote on blood pressure devices

          AdobeAnadvisorypaneltotheFoodandDrugAdministrationdeliveredasplitdecisiononasurgicalsystemusedinacon

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Venture capital firm's plans to take over Akron hospital face hurdles

          SummaHealthGeneralCatalysts’sgrandvisionforaventurecapital-ownedhospitalsystemseamlesslyblendingAIan